External counterpulsation combined with drug treatment for cerebral infarction has been widely used both domestically and internationally in the treatment of coronary heart disease, myocardial infarction, vertebral artery insufficiency, cerebral infarction, and other diseases. In recent years, we have enhanced external counterpulsation with drug treatment for 20 cases of cerebral infarction, achieving better therapeutic effects, which are reported as follows: clinical data in this article includes 20 patients who were outpatients and hospitalized patients, comprising 12 males and 8 females, the youngest being 36 years old and the oldest 68 years old, with an average age of 53.8 years. The shortest duration was three days, and the longest up to three years. Within a month of onset, there were 16 cases on one side, and 4 cases within 13 years. This group of diseases included 16 cases with external counterpulsation consciousness, four cases with mild sensory disorders and language problems. Right limb movement disorder (n = 14), six cases of left limb movement disorder, suffering from hypertension in 16 cases, including four cases of retinal arteriosclerosis grade Ⅲ, six cases of grade Ⅱ, and six cases of grade Ⅰ. Before in vitro anti-stroke confirmed by CT scan as acute cerebral infarction (n = 16), old cerebral infarction (n = 4). Atherosclerosis and hypertension are the most common causes of cerebral infarction, with main symptoms occurring in different parts such as vertigo, tinnitus, headache, poor responsiveness, unclear speech pronunciation, difficulty swallowing, high blood pressure, mouth askew, physical ataxia, cross-cutting paralysis, light hypoesthesia, individual patients may develop late dementia, severe cases coma and intracranial hypertension symptoms. Treatment was performed using Foshan Chinese Medical Instrument Co., Ltd.'s EECP --- Mc counterpulsation device. Once a day, one hour each, 12 sessions as a course of treatment, four courses for four cases, two courses for 12 cases, one course for 4 cases. Pressure: 0.03 ~ 0.04mPa, strictly controlling external counterpulsation contraindications, ECG monitoring downstream external counterpulsation. During external counterpulsation, conventional drug treatment continued. Conventional drug treatment principles include thrombolysis, blood pressure control, reducing blood viscosity, nutrition and other supportive symptomatic treatments. 25% glucose injection called Xuesaitong injection 0.4g, daily intravenous infusion of 1 or 10% glucose injection 25 dirty d, Dengzhanhua injection 30mg daily intravenous infusion of 1. Enteric-coated aspirin 25mg, 3 times a day orally, broadcast centimes tablets 25mg, 3 times a day orally, used to reduce blood viscosity. High blood pressure with nifedipine tablets 10mg, 3 times a day orally. Selected appropriate energy mixture Cerebrolysin and other nutritional support therapy according to interest. After EECP treatment, the original dizziness in 16 cases all disappeared. Four cases of mild sensory and language problems fully recovered after treatment. Among the 20 cases with motor and sensory disorders, 12 patients significantly improved after treatment (60%), and 8 cases improved (40%). For the 20 inverted cerebral infarction patients receiving enhanced external counterpulsation therapy, six cases underwent CT review comparison, but unfortunately other patients' economic conditions did not allow for review. The CT scan review showed that the cerebral infarction site had significantly narrowed in five cases, while the lesion site did not shrink but the edge became more defined. The purpose of treating cerebral infarction is to restore brain cell blood supply, striving to reduce the infarct size and reduce cerebral infarction and cerebral sequelae dysfunction. Drug thrombolysis, blood pressure control, reducing blood viscosity and nutritional support therapy, combined with external counterpulsation to increase cardiac output and cerebral blood flow perfusion at a higher level, thereby improving brain hypoxia and promoting brain cell recovery. External counterpulsation also accelerates blood flow, increases blood pressure and shear rate, leaving blood viscosity decreased, playing an important role in improving blood supply to the cerebral infarction area. External counterpulsation can significantly improve the blood supply of the heart and brain and other vital organs, indeed treating ischemic cardiovascular and cerebrovascular diseases, with data indicating an effective rate of 98%. Experimental proof shows that external counterpulsation is more effective than simple drug treatment, and drugs plus external counterpulsation treatment is better than simple external counterpulsation. This group of materials prompted that external counterpulsation plus drug treatment has a total efficiency of 100%, with a cure rate of 60% (12 cases) and improvement in 40% (8 cases). The choice of indications for external counterpulsation treatment, duration of disease, illness, and treatment timing are closely related, but their age is not obvious. Diagnosis should be established (cerebral infarction, ischemia), preferably confirmed by CT scan. While undergoing drug treatment, counterpulsation treatment outside the pension should be carried out as soon as possible, which will help restore brain injection pressure, increase cerebral blood flow, promote collateral circulation establishment, reduce the infarct area, improve symptoms, promote limb movements, and restore language function. In summary, in vitro anti-stroke as a non-invasive method of treatment for ischemic cerebrovascular disease, with increasing drug efficacy, safety, reliability, effectiveness, and quickness, should be promoted as routine treatment for ischemic cerebrovascular disease. (200o a 03-18 closing to ensure that this article edit Mu Dongsheng) suddenly.